Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04437511
Brief Title: A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

First Submitted : June 17, 2020
First Submitted that Met QC Criteria : June 17, 2020
First Posted : June 18, 2020

Last Update Submitted that Met QC Criteria : July 15, 2021
Last Update Posted : July 16, 2021